Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Adv Healthc Mater ; 5(3): 319-325, 2016 Feb 04.
Artigo em Inglês | MEDLINE | ID: mdl-26627057

RESUMO

Congenital heart defect interventions may benefit from the fabrication of patient-specific vascular grafts because of the wide array of anatomies present in children with cardiovascular defects. 3D printing is used to establish a platform for the production of custom vascular grafts, which are biodegradable, mechanically compatible with vascular tissues, and support neotissue formation and growth.


Assuntos
Materiais Biocompatíveis/química , Polímeros/química , Animais , Prótese Vascular , Células Cultivadas , Humanos , Camundongos , Impressão Tridimensional , Engenharia Tecidual/métodos , Alicerces Teciduais
2.
Biomacromolecules ; 16(2): 437-46, 2015 Feb 09.
Artigo em Inglês | MEDLINE | ID: mdl-25545620

RESUMO

Surface modification of biodegradable vascular grafts is an important strategy to improve the in situ endothelialization of tissue engineered vascular grafts (TEVGs) and prevent major complications associated with current synthetic grafts. Important strategies for improving endothelialization include increasing endothelial cell mobilization and increased endothelial cell capture through biofunctionalization of TEVGs. The objective of this study was to assess two biofunctionalization strategies for improving endothelialization of biodegradable polyester vascular grafts. These techniques consisted of cross-linking heparin to graft surfaces to immobilize vascular endothelial growth factor (VEGF) or antibodies against CD34 (anti-CD34Ab). To this end, heparin, VEGF, and anti-CD34Ab attachment and quantification assays confirmed the efficacy of the modification strategy. Cell attachment and proliferation on these groups were compared to unmodified grafts in vitro and in vivo. To assess in vivo graft functionality, the grafts were implanted as inferior vena cava interpositional conduits in mice. Modified vascular grafts displayed increased endothelial cell attachment and activity in vivo, according to microscopy techniques, histological results, and eNOS expression. Inner lumen diameter of the modified grafts was also better maintained than controls. Overall, while both functionalized grafts outperformed the unmodified control, grafts modified with anti-CD34Ab appeared to yield the most improved results compared to VEGF-loaded grafts.


Assuntos
Prótese Vascular , Materiais Revestidos Biocompatíveis/metabolismo , Heparina/metabolismo , Células Endoteliais da Veia Umbilical Humana/metabolismo , Enxerto Vascular/métodos , Animais , Antígenos CD34/metabolismo , Prótese Vascular/tendências , Materiais Revestidos Biocompatíveis/administração & dosagem , Materiais Revestidos Biocompatíveis/química , Feminino , Heparina/administração & dosagem , Heparina/química , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Humanos , Camundongos , Fator A de Crescimento do Endotélio Vascular/metabolismo , Enxerto Vascular/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...